Global Validation of PREVENT and SCORE2 Brings More Reliable Heart-Risk Predictions — and a Simple Urine Test May Sharpen Them
May 14, 2026 NEW YORK — A massive multinational analysis encompassing more than 6.4 million adults has confirmed that two of the world’s leading...
U.S. Overdose Deaths Fall for Third Straight Year, but Crisis Remains High and Uneven
New provisional federal data released by the Centers for Disease Control and Prevention (CDC) on May 13, 2026, indicate that drug overdose deaths in...
Eli Lilly Launches Donanemab (Lormalzi) in India — A Disease-Modifying Alzheimer’s Therapy Arrives Amid Cost and Access Questions
MUMBAI — In a landmark development for the treatment of neurodegenerative diseases in South Asia, Eli Lilly and Company officially launched...
HIV Treatment “Drop-Outs” Fall Sharply in 2025–26: What the Numbers Mean for Patients and Public Health
MUMBAI — In a significant milestone for India’s battle against HIV/AIDS, new data reveals a dramatic reduction in the number of patients...
FDA Approves BeOne’s Sonrotoclax as First Targeted Option for Relapsed Mantle-Cell Lymphoma — A Cautious Step Forward
WASHINGTON D.C. — The U.S. Food and Drug Administration (FDA) on May 13, 2026, approved sonrotoclax (brand name BEQALZI) from BeOne Medicines for...
